Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in, and brand-name confidence. The famous $199 compounded era ended in March 2026 after the Novo Nordisk settlement; new patients now route to branded products only.
That said, PlushCare wins on specific dimensions. PlushCare is a primary-care telehealth platform that happens to prescribe GLP-1s, not a GLP-1 specialist. That distinction makes it the strongest pick for the insured and the most expensive for everyone else.
Side-by-side
| Hims & Hers | PlushCare | |
|---|---|---|
| Starts from | $199/mo (incl. medication) | $19.99/mo (+ med separate) |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 1 day | 1 day |
| Consultation type | Asynchronous | Synchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Hims & Hers | PlushCare | |
|---|---|---|
| Pricing transparency | 7/10 | 5/10 |
| Cancellation terms | 9/10 | 7/10 |
| Onboarding experience | 9/10 | 9/10 |
| Medication options | 7/10 | 7/10 |
| Member outcomes | 5/10 | 8/10 |
When to choose Hims & Hers
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable all-in monthly pricing.
When to choose PlushCare
Patients with commercial insurance that covers Wegovy or Zepbound. PlushCare's PCPs handle prior authorization paperwork well.
FAQ
Is Hims & Hers cheaper than PlushCare?
Can I switch from Hims & Hers to PlushCare mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →